Robuta

https://nouveau.univ-brest.fr/lbai/en/page/publications-spotlight?q=fr/page/publications-lhonneur Publications in the spotlight | B Lymphocytes, Autoimmunity and Immunotherapies - UMR 1227 in the spotlightb lymphocytespublicationsautoimmunityimmunotherapies https://magazine-local.medlineplus.gov/article/ovarian-cancer-immunotherapies-show-promise Ovarian cancer immunotherapies show promise | NIH MedlinePlus Magazine Ovarian cancer research focuses on the innate immune system, the first line of defense against invading pathogens. nih medlineplus magazineovarian cancerimmunotherapiesshowpromise https://skillsacademy.newcastle-hospitals.nhs.uk/courses/category/advanced-training-on-cancer-biology-targeted-and-immunotherapies/2024-09/ Courses for September 2024 › Advanced training on cancer biology, targeted and immunotherapies › –... advanced trainingcancer biologycoursesseptembertargeted https://skillsacademy.newcastle-hospitals.nhs.uk/courses/category/advanced-training-on-cancer-biology-targeted-and-immunotherapies/ Upcoming Courses › Advanced training on cancer biology, targeted and immunotherapies › – Newcastle... upcoming coursesadvanced trainingcancer biologytargetedimmunotherapies https://www.brightsurf.com/news/1EOJD3QL/usc-study-explores-new-insights-into-innate-resistance-for-immunotherapies-in-colorectal-cancer.html USC study explores new insights into innate resistance for immunotherapies in colorectal cancer Researchers found higher levels of CD47 expression linked to more aggressive tumors, immune cells, and oncogenic signaling. Targeting CD47 could lead to… colorectal canceruscstudyexploresnew https://www.myeloma.org/resource-library/imwg-immunotherapy-committee-recommendation-sequencing-immunotherapy-treatment IMWG on Sequencing Immunotherapies | Int'l Myeloma Foundation T-cell redirecting therapies (TCRTs), including CAR T-cell therapy and bispecific T-cell engagers (TCEs), are transforming how multiple myeloma (MM) is... myeloma foundationsequencingimmunotherapiesint https://www.patlynk.com/fr/trial/NCT00004198 A Phase II Trial to Evaluate the Rate of Immune Response Using Idiotype Immunotherapies Produced by... OBJECTIVES: I. Determine the ability of recombinant idiotype immunotherapy to stimulate a specific immune response against the B cell idiotype of the malignant phase ii trialimmune responseproduced byevaluaterate https://gynecancerinitiative.ca/advancing-immunotherapies-for-ovarian-cancer/ Advancing immunotherapies for ovarian cancer - Gynecologic Cancer Initiative Sep 17, 2026 - This September, for Gynecologic Cancer Awareness Month, we are spotlighting the innovative discoveries supported through GCI Internal Awards that are... ovarian canceradvancingimmunotherapiesgynecologicinitiative https://resources.jax.org/youtube-next-generation-humanized-models-102024/yang-10292024 Humanized Mice for the Assessment of the Safety of Immunotherapies humanized micefor theassessmentsafetyimmunotherapies https://globalhealthnewswire.com/research/2024/05/05/newly-discovered-mechanism-of-t-cell-control-can-interfere-with-cancer-immunotherapies Newly Discovered Mechanism of T-Cell Control Can Interfere with Cancer Immunotherapies – Global... t cellnewlydiscoveredmechanismcontrol https://www.onclive.com/view/dr-neeraj-agarwal-on-prostvac-and-other-immunotherapies-in-prostate-cancer Dr. Neeraj Agarwal on PROSTVAC and Other Immunotherapies in Prostate Cancer | OncLive Oct 15, 2026 - Neeraj Agarwal, MD associate professor in the Division of Oncology, Department of Medicine, director of the Genitourinary Medical Oncology Program, Huntsman... prostate cancerneerajagarwalprostvacimmunotherapies https://www.seattlechildrens.org/research/centers-programs/childhood-cancer/our-labs/carbone-lab/ Carbone Lab - Center for Immunity and Immunotherapies The Carbone Lab investigates the master role of dendritic cells (DCs) in orchestrating immune responses, with a focus on their impact in cancer immunotherapy.... carbonelabcenterimmunityimmunotherapies https://bioengineer.org/su2c-awards-11m-in-grants-to-investigate-immunotherapies-using-ai-with-microsoft-support/ SU2C awards $11M in grants to investigate immunotherapies using AI with Jan 30, 2018 - Credit: Stand Up To Cancer Santa Monica, CA (January 30, 2018) — Stand Up To Cancer (SU2C) announces today a "Convergence 2.0" research initiative that awards... using aiawardsgrantsinvestigateimmunotherapies https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.607583/full Frontiers | COVID-19: Imbalanced Immune Responses and Potential Immunotherapies The ongoing pandemic coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading and has ... immune responsesfrontierscovidimbalancedpotential https://www.phaim.co.uk/ Phaim | Novel immunotherapies, starting with type 1 diabetes Phaim is a UK BioTech company developing a new category of therapeutics, designed to cure, improve, halt or prevent autoimmune disease. starting withnovelimmunotherapiestypediabetes https://www.sciencedaily.com/releases/2015/04/150423143239.htm 'Humanized' mice will lead to better testing of cancer immunotherapies | ScienceDaily New model XactMice, uses human blood stem cells to grow a 'humanized' mouse immune system prior to tumor transplantation, allowing anti-cancer therapies to be... humanized micelead tobettertestingcancer https://sciencemission.com/immunotherapies-for-childhood-cancers Tailoring immunotherapies for childhood cancers - Sciencemission childhood cancerstailoringimmunotherapies